Abstract
Objective
Nearly 1.5 billion people of an Asian country are living their lives without a country-specific over-the-counter (OTC) drug list. A study was planned to assess the understanding and practice of OTC medication consumption in the pregnant population.
Methods
A questionnaire-based cross-sectional study evaluating different perspectives on OTC drug consumption was planned in around 500 pregnant women attending tertiary care outpatient antenatal clinics. The association of knowledge, attitude and practice versus indications, knowledge regarding harmful effects possible, reasons for choosing OTC medication, the practice of consulting nonmedical persons and drug interactions with the disease or prescription medications was determined. Regression analysis was performed in statistical software R.
Results
Seven percent (36/516) of pregnant women were found to consume oral antimicrobials without prescription. Local chemist consultation was the most common channel (72.48%) to procure the OTC medicines. Participants with good knowledge score showed an odds ratio (OR) of 1.87 (95% C.I.; 1.28–2.73), 1.6 (95% C.I.; 0.99–2.63), 1.66 (95% C.I.; 1.14–2.42) and 2.66 (95% C.I.; 1.49–4.89) for self-medication encouragement tendency possible, restricting sale of OTC medications, the habit of reading drug leaflets and understanding the potentially harmful effects, with OTC drugs, respectively. Right-attitude participants showed an OR of 1.89 (95% C.I.; 1.29–2.80) and 1.8 (95% C.I.; 1.19–2.76) for identifying knowledge of acetaminophen overdose and liver damage link as well as the disease symptom masking possibility with OTC, respectively. Participants with insufficient knowledge and attitude scores showed an association with more OTC antacid-antiemetics and analgesic use, respectively.
Conclusion
Antenatal pregnant women need to be guided on avoiding OTC antimicrobial usage. Both obstetricians and regulators have to play an active role in educating pregnant women and contributing to developing country-specific OTC drug lists with the guidelines.
Similar content being viewed by others
References
Arora A, Patil A. Time to take stock of Indian regulatory guidelines regarding drug use in pregnancy and lactation. Indian J Pharmacol. 2019;51(2):126–7.
van der Graaf R, van der Zande ISE, den Ruijter HM, Oudijk MA, van Delden JJM, Oude Rengerink K, Groenwold RHH. Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach. Trials. 2018;19(1):78. https://doi.org/10.1186/s13063-017-2402-9 (PMID: 29378652; PMCID: PMC5789693).
Sheffield JS, Siegel D, Mirochnick M, et al. Designing drug trials: considerations for pregnant women. Clin Infect Dis. 2014;59(Suppl7):S437–44. https://doi.org/10.1093/cid/ciu709.
Patil AN, Padhy BM, Prasanthi SK, Rohilla R. Drug information center in India: overview, challenges and future prospects. International Journal of Pharmaceutical Investigation. 2018;8(1):01–6.
Kumar P, Patil A, Kakkar AK, Singh H. Decoding the roadmap for capacity building of pharmacology academicians in catering to drug information center services in a developing country. J Pharm Technol. 2019;35(4):146–54.
Servey J, Chang J. Over-the-counter medications in pregnancy. Am Fam Physician. 2014;90(8):548–55.
Lynch MM, Squiers LB, Kosa KM, Dolina S, Read JG, Broussard CS, et al. Making decisions about medication use during pregnancy: implications for communication strategies. Matern Child Health J. 2018;22(1):92–100.
Marathe PA, Kamat SK, Tripathi RK, Raut SB, Khatri NP. Over-the-counter medicines: Global perspective and Indian scenario. J Postgrad Med. 2020;66(1):28–34.
Gupta YK, Ramachandran SS. Fixed dose drug combinations: Issues and challenges in India. Indian J Pharmacol. 2016;48(4):347–9.
Kumar-M P, Mahajan R, Kathirvel S, Hegde N, Kakkar AK, Patil AN. Developing a latent class analysis model to identify at-risk populations among people using medicine without prescription. Expert Rev Clin Pharmacol. 2020;13(12):1411–22.
Chandra S, Patwardhan K. Allopathic, AYUSH and informal medical practitioners in rural India - a prescription for change. J Ayurveda Integr Med. 2018;9(2):143–50.
Ventola CL. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? P T. 2011;36(10):669–84.
Sheffield JS, Siegel D, Mirochnick M, Heine RP, Nguyen C, Bergman KL, et al. Designing drug trials: considerations for pregnant women. Clin Infect Dis. 2014;15(59 Suppl 7):S437-444.
Bajpai V. The challenges confronting public hospitals in India, their origins, and possible solutions [Internet]. Vol. 2014, Advances in Public Health. Hindawi; 2014 [cited 2020 Apr 13]. p. e898502. Available from: https://www.hindawi.com/journals/aph/2014/898502/.
Aanensen DM, Huntley DM, Menegazzo M, Powell CI, Spratt BG. EpiCollect+: linking smartphones to web applications for complex data collection projects. F1000Res. 2014;20(3):199.
RTeam RC. R: a language and environment for statistical computing. 2019.
Wickham H. ggplot2: elegant graphics for data analysis. NewYork: Springer; 2016.
Lüdecke D. sjPlot: data visualization for statistic in social science. R Package Version 2.8.4. 2020.
Lawrence MA. ez: easy analysis and visualization of factorial experiments. R Package Version 4.4–0. 2016.
Bennadi D. Self-medication: a current challenge. J Basic Clin Pharm. 2013;5(1):19–23.
Abduelkarem AR, Mustafa H. Use of Over-the-Counter Medication among Pregnant Women in Sharjah, United Arab Emirates. J Pregnancy. 2017;2017:4503793.
Navaro M, Vezzosi L, Santagati G, Angelillo IF, Collaborative Working Group. Knowledge, attitudes, and practice regarding medication use in pregnant women in Southern Italy. PLoS One. 2018;13(6):e0198618.
Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015;11(1):67–77.
Murchison L, De Coppi P, Eaton S. Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Pediatr Surg Int. 2016;32(12):1147–52.
Bologa-Campeanu M, Koren G, Rieder M, McGuigan M. Prenatal adverse effects of various drugs and chemicals. A review of substances of frequent concern to mothers in the community. Med Toxicol Adverse Drug Exp. 1988;3(4):307–23. https://doi.org/10.1007/BF03259942 (PMID: 3054428).
Chatterjee S, Levin C, Laxminarayan R. Unit cost of medical services at different hospitals in India. PLoS ONE. 2013;8(7):e69728.
Ahmad A, Patel I, Khan MU, Chang J. Can pharmacy doctors act as valuable assets in rural areas with a physician shortage? J Res Pharm Pract. 2014;3(4):109–11.
Lopez FL, Ernest TB, Tuleu C, Gul MO. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opin Drug Deliv. 2015;12(11):1727–40.
Ofori-Asenso R, Agyeman AA. Irrational use of medicines-a summary of key concepts. Pharmacy Basel. 2016;4(4):35.
Blaiss MS, Food and Drug Administration (U.S.), ACAAI-ACOG (American College of Allergy, Asthma, and Immunology and American College of Obstetricians and Gynecologists). Management of rhinitis and asthma in pregnancy. Ann Allergy Asthma Immunol. 2003;90(6):16-22.
Kargas GA, Kargas SA, Bruyere HJ, Gilbert EF, Opitz JM. Perinatal mortality due to interaction of diphenhydramine and temazepam. N Engl J Med. 1985;313(22):1417–8.
Stock SJ, Norman JE. Medicines in pregnancy. F1000Res. 2019;8:911.
Rasheed P, Koura MR, Al-Dabal BK, Makki SM. Anemia in pregnancy: a study among attendees of primary health care centers. Ann Saudi Med. 2008;28(6):449–52. https://doi.org/10.5144/0256-4947.2008.449 (PMID: 19011314; PMCID: PMC6074263).
Kassaw C, Wabe NT. Pregnant women and non-steroidal anti-inflammatory drugs: knowledge, perception and drug consumption pattern during pregnancy in ethiopia. N Am J Med Sci. 2012;4(2):72–6. https://doi.org/10.4103/1947-2714.93377 (PMID: 22408751; PMCID: PMC3296322).
Guo H, Sun J, Li D, Hu Y, Yu X, Hua H, Jing X, Chen F, Jia Z, Xu J. Shikonin attenuates acetaminophen-induced acute liver injury via inhibition of oxidative stress and inflammation. Biomed Pharmacother. 2019;112:108704. https://doi.org/10.1016/j.biopha.2019.108704 (Epub 2019 Feb 25. PMID: 30818140).
Blehar MC, Spong C, Grady C, Goldkind SF, Sahin L, Clayton JA. Enrolling pregnant women: issues in clinical research. Womens Health Issues. 2013;23(1):e39-45.
Schulz R, Eden J, Adults C on .C.F.C. for O, Services B on H.C., Division H and M, National Academies of Sciences E. Family caregiving roles and impacts [Internet]. Families caring for an aging America. National Academies Press (US); 2016 [cited 2020 Apr 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK396398/.
Kline KL, Westberg SM. Over-the-counter medication use, perceived safety, and decision-making behaviors in pregnant women. Innovations in pharmacy [Internet]. 2011 Jan 1 [cited 2020 Apr 13];2(1). Available from: https://pubs.lib.umn.edu/index.php/innovations/article/view/218.
Acknowledgements
Authors would like to thank all study participant antenatal clinic visitors for the participation in the study and thank all study participant pregnant women, Mr. Himanshu Chaudhary and Mr Sunil Sharma for data collection and compilation.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Human or Animal Rights
Yes. The study received approval from the Institutional Ethics Committee with permission No. INT/IEC/2019/001760 dated August 28, 2019.
Informed Consent
Written informed consent was obtained from the study participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Aashima Arora is an Associate Professor in Department of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. A. N. Patil. and A. Arora.: Contributed to conception, data check, execution of the entire study; A.Arora and Praveen Kumar-M: data analysis along with data extraction; A. Anand, L. Saha, P. K. Saha A. Kumar and H Shendge: Important intellectual content, literature review, and final approval; Praveen Kumar M and A. N. Patil: Manuscript writing and finalized important intellectual content. All authors critically revised the content.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Arora, A., Praveen Kumar, M., Anand, A. et al. Identification of At-risk Pregnant Population for Over-the-Counter Drug Usage in Low-Resource Settings. J Obstet Gynecol India 71, 600–608 (2021). https://doi.org/10.1007/s13224-021-01481-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-021-01481-2